LMT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lockheed Martin Corp (LMT) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has secured significant contracts and maintains a strong position in the defense sector, its financial performance in Q1 2026 shows declining net income, EPS, and gross margin. Technical indicators suggest the stock is oversold, but the negative MACD and lack of clear upward momentum make it less appealing for immediate entry. Analysts are mixed, with price targets ranging widely and concerns about growth and cash flow risks. Options sentiment is neutral to slightly bullish, but hedge funds are selling, which adds to the uncertainty.
The MACD is negative and expanding (-8.13), indicating bearish momentum. RSI at 6.882 suggests the stock is oversold, but moving averages are converging without a clear trend. Key support is at 539.768, with resistance at 578.064. The stock is trading below its pivot level, showing weakness.
Lockheed Martin has secured multiple contracts, including a $1.5 billion deal with the Peruvian Air Force and a $4.7 billion Pentagon contract. The U.S. Air Force's plan to purchase 4,300 missiles over five years also supports long-term demand. Additionally, the company is expanding production capacity to meet growing demand.
Q1 2026 earnings missed expectations, with net income down 13.08% YoY and EPS down 11.54% YoY. Hedge funds are selling the stock, with a significant increase in selling activity (143.99%). Analysts have mixed views, with concerns about slower growth, weaker free cash flow, and margin risks from fixed-price programs.
In Q1 2026, revenue increased marginally by 0.32% YoY to $18.02 billion. However, net income dropped 13.08% YoY to $1.488 billion, and EPS fell 11.54% YoY to $6.44. Gross margin also declined by 10.83% YoY to 11.53%, indicating operational challenges.
Analysts are mixed on LMT. Jefferies, Citi, and Wells Fargo maintain neutral or hold ratings, citing flat revenue growth and risks to margins and cash flow. Susquehanna and BofA are more optimistic, highlighting strong demand and medium-term growth potential. Price targets range from $517 (Goldman Sachs) to $740 (Susquehanna), reflecting uncertainty in the stock's outlook.
